Screening of cytochrome 4Z1 expression in human non-neoplastic, pre-neoplastic and neoplastic tissues.
Conclusion: These findings greatly support future plans for the use of CYP4Z1 as a biomarker or target for anti-cancer drugs. However, large-scale validation studies are needed to better delineate the potential use of CYP4Z1 for therapeutic purposes.
PMID: 33144882 [PubMed]
Source: Ecancermedicalscience - Category: Cancer & Oncology Tags: Ecancermedicalscience Source Type: research
More News: Adenocarcinoma | Astrocytoma | Breast Carcinoma | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Cervical Cancer | Endometrial Cancer | Esophagus Cancer | HER2 | Melanoma | Oesophagus | Pathology | Seminoma | Skin Cancer | Study | Testicular Cancer